<p>Up-to-date data on combination therapy of arterial hypertension in patients with chronic kidney disease are presented. Special attention is paid to the fixed combination of calcium antagonist lercanidipine and angiotensin-converting enzyme inhibitor enalapril.</p
In all actual clinical guidelines, dihydropyridine calcium channel blockers (CCBs) belong to the rec...
ABSTRACT. CALCIUM ANTAGONISTS are first-line antihypertensive agents but their effects in patients w...
Despite extensive debate about the first choice for treating essential hypertension, monotherapy eff...
Vivencio Barrios1, Carlos Escobar2, Rocio Echarri31Department of Cardiology, Hospital Ramón y...
Christina Antza,1 Stella Stabouli,2 Vasilios Kotsis1 1Hypertension Center, Third Department of Medic...
Hypertension, a significant factor in the development of cerebrovascular disorders, heart disease an...
Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.Ove...
The article is a short overview of articles related to the prescription of combination antihypertens...
Hypertension and high levels of proteinuria are independent risk factors for accelerated progression...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
Pharmacological treatment of hypertension is effective in preventing cardiovascular and renal compli...
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers are considered the stan...
The review is devoted to the problem of kidney damage as the arterial hypertension target organ. The...
Abstract Background: Clinical research in the field of hypertension is now increasingly focusing on ...
Nephropathy progression is slowed and cardiovascular events reduced in patients with stage 3 or high...
In all actual clinical guidelines, dihydropyridine calcium channel blockers (CCBs) belong to the rec...
ABSTRACT. CALCIUM ANTAGONISTS are first-line antihypertensive agents but their effects in patients w...
Despite extensive debate about the first choice for treating essential hypertension, monotherapy eff...
Vivencio Barrios1, Carlos Escobar2, Rocio Echarri31Department of Cardiology, Hospital Ramón y...
Christina Antza,1 Stella Stabouli,2 Vasilios Kotsis1 1Hypertension Center, Third Department of Medic...
Hypertension, a significant factor in the development of cerebrovascular disorders, heart disease an...
Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.Ove...
The article is a short overview of articles related to the prescription of combination antihypertens...
Hypertension and high levels of proteinuria are independent risk factors for accelerated progression...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
Pharmacological treatment of hypertension is effective in preventing cardiovascular and renal compli...
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers are considered the stan...
The review is devoted to the problem of kidney damage as the arterial hypertension target organ. The...
Abstract Background: Clinical research in the field of hypertension is now increasingly focusing on ...
Nephropathy progression is slowed and cardiovascular events reduced in patients with stage 3 or high...
In all actual clinical guidelines, dihydropyridine calcium channel blockers (CCBs) belong to the rec...
ABSTRACT. CALCIUM ANTAGONISTS are first-line antihypertensive agents but their effects in patients w...
Despite extensive debate about the first choice for treating essential hypertension, monotherapy eff...